Medical Technologies

Control Material for Quantitative Determination of IgG Antibodies to SARS-CoV-2

Control Material for Quantitative Determination of IgG Antibodies to SARS-CoV-2

This control material is designed to assess the quality of quantitative determination of IgG antibodies to the RBD domain of the S protein of SARS-CoV-2 in clinical samples using the immunochemiluminescent method on CL series analyzers. This product is available in lot 2021060100.

Option 1:

Control Material for High-Level Assessment (SARS-CoV-2 S-RBD IgG Antibody Control (H)) is provided in 6 x 0.5 ml vials per kit. Each vial contains 0.5 ml. The kit also includes a table of values for the series of control materials and an instruction manual.

Option 2:

Control Material for Low-Level Assessment (SARS-CoV-2 S-RBD IgG Antibody Control (L)) is provided in 6 x 0.5 ml vials per kit. Each vial contains 0.5 ml. The kit also includes a table of values for the series of control materials and an instruction manual.

To purchase this control material, you can fill out an application form on our website or use the order form available online. Alternatively, you can send an email to Адрес электронной почты защищен от спам-ботов. Для просмотра адреса в вашем браузере должен быть включен Javascript..

Copyright MAXXmarketing GmbH
JoomShopping Download & Support